Target Name: NLRP14
NCBI ID: G338323
Review Report on NLRP14 Target / Biomarker Content of Review Report on NLRP14 Target / Biomarker
NLRP14
Other Name(s): NACHT, leucine rich repeat and PYD containing 14 | NACHT, LRR and PYD containing protein 14 | nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 14 | NLR family pyrin domain containing 14 | GC-LRR | NOD5 | NAL14_HUMAN | PAN8 | CLR11.2 | Nucleotide-binding oligomerization domain protein 5 | nucleotide-binding oligomerization domain protein 5 | NACHT, LRR and PYD domains-containing protein 14 | NALP14

NLRP14: A Protein Regulator of Cellular Processes

NLRP14 (Nacht, Leucine Rich Repeat and PYD Containing 14) is a protein that is expressed in various tissues throughout the body. It is a key regulator of the non-coding RNA (ncRNA) domain, which is a class of RNA molecules that play a crucial role in post-transcriptional gene regulation. NLRP14 is also known as PYD-like protein 14 and is composed of three domains: a N-terminal domain, a C-terminal domain, and a P-domain.

The N-terminal domain of NLRP14 contains a unique N-terminal region that is composed of a long sequence of leucine rich repeats. These repeats are important for the stability and functions of the protein. The C-terminal domain of NLRP14 contains a series of conserved amino acid residues that are involved in the formation of a structural complex with other proteins. The P-domain of NLRP14 is a unique region that is involved in the regulation of the activity of the protein.

One of the key functions of NLRP14 is its role in the regulation of gene expression. It is well known that NLRP14 plays a role in the regulation of various gene expression pathways, including the response to stress, the regulation of inflammation, and the regulation of cell growth.

In addition to its role in gene expression, NLRP14 is also involved in the regulation of protein stability and cell signaling pathways. It is well known that NLRP14 is involved in the regulation of the stability of various proteins, including its own protein. It is also involved in the regulation of cell signaling pathways, including the TGF-β pathway.

Given its involvement in a wide range of cellular processes, NLRP14 is a promising drug target. There is ongoing research into the use of small molecules and other compounds to modulate the activity of NLRP14 and its downstream targets. These compounds have the potential to be used for a variety of therapeutic applications, including the treatment of various diseases.

In conclusion, NLRP14 is a protein that plays a crucial role in the regulation of various cellular processes. Its unique N-terminal domain, C-terminal domain, and P-domain make it an attractive target for small molecules and other compounds that can be used for therapeutic applications. Further research is needed to fully understand the role of NLRP14 in cellular processes and to develop effective treatments for various diseases.

Protein Name: NLR Family Pyrin Domain Containing 14

Functions: May be involved in inflammation and spermatogenesis

The "NLRP14 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NLRP14 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NLRP2 | NLRP2B | NLRP3 | NLRP3 Inflammasome | NLRP3P1 | NLRP4 | NLRP5 | NLRP6 | NLRP7 | NLRP8 | NLRP9 | NLRP9P1 | NLRX1 | NMB | NMBR | NMD3 | NMDA receptor | NME1 | NME1-NME2 | NME2 | NME2P1 | NME3 | NME4 | NME5 | NME6 | NME7 | NME8 | NME9 | NMI | NMNAT1 | NMNAT2 | NMNAT3 | NMRAL1 | NMRAL2P | NMRK1 | NMRK2 | NMS | NMT1 | NMT2 | NMTRQ-TTG10-1 | NMTRQ-TTG12-1 | NMTRV-TAC1-1 | NMU | NMUR1 | NMUR2 | NNAT | NNMT | NNT | NNT-AS1 | NOA1 | NOB1 | NOBOX | NOC2L | NOC2LP2 | NOC3L | NOC4L | NOCT | NOD1 | NOD2 | NODAL | NOG | NOL10 | NOL11 | NOL12 | NOL3 | NOL4 | NOL4L | NOL4L-DT | NOL6 | NOL7 | NOL8 | NOL9 | NOLC1 | NOM1 | NOMO1 | NOMO2 | NOMO3 | Non-protein coding RNA 185 | NONO | NOP10 | NOP14 | NOP14-AS1 | NOP16 | NOP2 | NOP53 | NOP56 | Nop56p-associated pre-rRNA complex | NOP58 | NOP9 | NOPCHAP1 | NORAD | NOS1 | NOS1AP | NOS2 | NOS2P1 | NOS2P2 | NOS2P3 | NOS3 | NOSIP | NOSTRIN